Solara Active Pharma Sciences Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 4,252.4 million compared to INR 3,383.7 million a year ago. Revenue was INR 4,264.2 million compared to INR 3,420.9 million a year ago. Net loss was INR 171.6 million compared to INR 99.6 million a year ago. Basic loss per share from continuing operations was INR 4.77 compared to INR 2.77 a year ago. Diluted loss per share from continuing operations was INR 4.77 compared to INR 2.77 a year ago.
For the six months, sales was INR 7,775.5 million compared to INR 6,684.4 million a year ago. Revenue was INR 7,807.7 million compared to INR 6,791.4 million a year ago. Net loss was INR 367.1 million compared to INR 263.9 million a year ago. Basic loss per share from continuing operations was INR 10.2 compared to INR 7.33 a year ago. Diluted loss per share from continuing operations was INR 10.2 compared to INR 7.33 a year ago.